Ulf Darsow

Ulf Darsow

Auto-generated profile, based on publicly available information

Ulf Darsow

Technische Universität München

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2012 in Die Dermatologie
Verified
Journal Article
Closed access
PDF file
SSSonja Stander
Sonja Stander
CBC. Blome
C. Blome
BBB. Breil
B. Breil
PBP. Bruland
P. Bruland
UDU. Darsow
U. Darsow
MAM. Augustin
M. Augustin

1 May 2016 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
SRSophie Roenneberg
Sophie Roenneberg
ABAlexander Böhner
Alexander Böhner
KBKnut Brockow
Knut Brockow
AAAlexander Arnold
Alexander Arnold
UDUlf Darsow
Ulf Darsow
TBTilo Biedermann
Tilo Biedermann

29 June 2016 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
UDU. Darsow
U. Darsow
MSM. Sbornik
M. Sbornik
SRS. Rombold
S. Rombold
KKK. Katzer
K. Katzer
FSF. von Sonnenburg
F. von Sonnenburg
JRJ. Ring
J. Ring

10 August 2021 in Toxins
Verified
Journal Article
Open access
PDF file
JGJohannes Grosch
Johannes Grosch
BEBernadette Eberlein
Bernadette Eberlein
SWSebastian Waldherr
Sebastian Waldherr
MPMariona Pascal
Mariona Pascal
CBClara San Bartolomé
Clara San Bartolomé
Simon BlankSimon Blank
Simon Blank
Discriminating Polistes dominula and Vespula spp. venom allergy is of growing importance worldwide, as systemic reactions to either species’ sting can lead to severe outcomes. Administering the correct allergen-specific immunotherapy is therefore a prerequisite to ensure the safety and health of venom-allergic patients. Component-resolved diagnostics of Hymenoptera venom allergy might be improved by adding additional allergens to the diagnostic allergen panel. Therefore, three potential new allergens from P. dominula venom—immune responsive protein 30 (IRP30), vascular endothelial growth factor C (VEGF C) and phospholipase A2 (PLA2)—were cloned, recombinantly produced and biochemically characterized. Sera sIgE titers of Hymenoptera venom-allergic patients were measured in vitro to assess the allergenicity and potential cross-reactivity of the venom proteins. IRP30 and VEGF C were classified as minor allergens, as sensitization rates lay around 20–40%. About 50% of P. dominula venom-allergic patients had measurable sIgE titers directed against PLA2 from P. dominula venom. Interestingly, PLA2 was unable to activate basophils of allergic patients, questioning its role in the context of clinically relevant sensitization. Although the obtained results hint to a questionable benefit of the characterized P. dominula venom proteins for improved diagnosis of venom-allergic patients, they can contribute to a deeper understanding of the molecular mechanisms of Hymenoptera venoms and to the identification of factors that determine the allergenic potential of proteins.

28 August 2023 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
RBRebekka Karolin Bent
Rebekka Karolin Bent
CKClaudia Kugler
Claudia Kugler
VFValentina Faihs
Valentina Faihs
UDUlf Darsow
Ulf Darsow
TBTilo Biedermann
Tilo Biedermann
KBKnut Brockkow
Knut Brockkow

13 March 2012
Verified
Book Chapter
Closed access
PDF file
UDUlf Darsow
Ulf Darsow
FPFlorian Pfab
Florian Pfab
MVMichael Valet
Michael Valet
TTThomas R. Tölle
Thomas R. Tölle
Johannes RingJohannes Ring
Johannes Ring
Eczema/dermatitis belongs to the most pruritic of skin diseases. Pruritogenic mediators in the skin are still mostly unknown. Recent studies, however, have shown that the histamine 4 receptor plays an